Citations 731
Differential Impact on Survival in Myeloid Neoplasm Patients with U2AF1 Mutations
Vanegas, Yenny Moreno , Nanaa, Ahmad , Al‐Kali, Aref , He, Rong , Patnaik, Mrinal M. , Gangat, Naseema , Litzow, Mark R. , Tefferi, Ayalew , Alkhateeb, Hassan B. , Shah, Meera , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9602-9603
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287
A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed IDH2-Mutant AML Patients: 3-Year Follow-up
Stein, Eytan M. , Huang, Ying , Dunbar, Andrew , Baer, Maria R. , Kovacsovics, Tibor , Blum, William , Schiller, Gary J. , Olin, Rebecca L. , Foran, James M. , Litzow, Mark R. , Patel, Prapti A. , Boyiadzis, Michael , Collins, Robert H. , Chervin, Jordan , Vergilio, Jo‐Anne, Heerema, Nyla A. , Rosenberg, Leonard, Yocum, Ashley O. , Druggan, Franchesca , Marcus, Sonja, Stefanos, Mona , Martycz, Molly , Borate, Uma , Burd, Amy , Byrd, John C. , Byrd, John C , Cai, Sheng F , Stock, Wendy , Lin, Tara L. , Foster, Matthew C , Shoben, Abigail B. , Chen, Timothy Frank , Druker, Brian J , Mims, Alice S , Levine, Ross L.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2016-2019
Characteristics and Prognostic Effects of DNMT3A Co-Mutations
Torabi, Alireza , Gerbing, Robert B., Wang, Yicheng , Radich, Jerald P. , Appelbaum, Frederick R. , O'Dwyer, Kristin, Tallman, Martin S. , Litzow, Mark R. , Luger, Selina M. , Kolb, Anders, Stirewalt, Derek, Paietta, Elisabeth , Meshinchi, Soheil, Alonzo, Todd A. , Othus, Megan , Ries, Rhonda E. , Erba, Harry Paul , Atallah, Ehab , Abdel‐Wahab, Omar , Levine, Ross L. , Meshinchi, Soheil
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 745-747
Younger Matched Unrelated Donors Confer a Decreased Relapse Risk As Compared to Older Sibling Donors for Adult B-Cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation
Estrada‐Merly, Noel, Zhang, Mei‐Jie , Chen, Karen , Bredeson, Christopher , Litzow, Mark R. , Saber, Wael , Abid, Muhammad Bilal , Allan, David , Sabloff, Mitchell , Kebriaei, Partow
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10540-10541
DNA Polymerase Theta Protects Leukemia Cells from Metabolic-Induced DNA Damage
Vekariya, Umeshkumar M, Sullivan-Reed, Katherine , Toma, Monika M. , Nieborowska-Skorska, Margaret , Caron, Marie‐Christine, Kukuyan, Anna-Mariya, Atkins, Jessica , Drzewiecka, Małgorzata , Feng, Wanjuan, Golovine, Konstantin, Ghosh, Jayashri , Maslawska-Wasowska, Ksenia, Nejati, Reza , Wasik, Mariusz A. , Pomerantz, Richard T. , Morton, George , Paietta, Elisabeth , Tallman, Martin S. , Fernández, Hugo F. , Litzow, Mark R. , Toma, Monika , Drzewiecka, Malgorzata , Vekariya, Umeshkumar , Le, Bac Viet , Podszywalow‐Bartnicka, Paulina , Chitrala, Kumaraswamy Naidu , Chan, Joe , Jelı́nek, Jaroslav , Śliwiński, Tomasz , Sykes, Stephen M. , Piwocka, Katarzyna , Hadzijusufovic, Emir , Valent, Peter , Childers, Wayne , Zhao, Huaqing , Levine, Ross L. , Gupta, Gaorav P , Masson, Jean‐Yves , Skórski, Tomasz
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2972-2974
Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia
Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12238-12240
Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021
Abdelmagid, Maymona, Al‐Kali, Aref , Begna, Kebede H. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Elliott, Michelle A. , Howard, Matthew O. , Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Hogan, William J. , Alkhateeb, Hassan B. , Shi, Min , Howard, Matthew, Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9735-9736